BA
ALPN

BlackRock Advisors’s Alpine Immune Sciences Inc ALPN Stock Holding History

BlackRock Advisors’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4K Hold
403
– – ﹤0.01% 3648
2016
Q3 		$13K Sell
403
-53
-12% -$1.29K ﹤0.01% 3536
2016
Q2 		$8K Buy
456
+150
+49% +$2.66K ﹤0.01% 3619
2016
Q1 		$5K Buy
306
+110
+56% +$2.2K ﹤0.01% 3669
2015
Q4 		$6K Sell
196
-169
-46% -$5.77K ﹤0.01% 3700
2015
Q3 		$19K Sell
365
-32,810
-99% -$2.16M ﹤0.01% 3529
2015
Q2 		$2.01M Buy
+33,175
New +$1.98M ﹤0.01% 1268

Other funds holding ALPN

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Advisors's ALPN Position: Q4 2016 in Review

BlackRock Advisors held its Alpine Immune Sciences Inc (ALPN) position steady in Q4 2016 at 403 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3648.

BlackRock Advisors first reported a position in ALPN in Q2 2015 and has held it in 7 quarters since. The position peaked at $2.01M in Q2 2015. 38 funds tracked by Wall St. Rank hold ALPN as of Q4 2016.

  • BlackRock Advisors held 403 shares of Alpine Immune Sciences Inc worth $4K as of Q4 2016.
  • BlackRock Advisors left its Alpine Immune Sciences Inc share count unchanged in Q4 2016.
  • Alpine Immune Sciences Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3648 holding.
  • BlackRock Advisors first reported a position in Alpine Immune Sciences Inc in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Advisors's Alpine Immune Sciences Inc position peaked at $2.01M in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.